ProSomnus, Inc. (OSA)

Overall impact
C (47)

Commentary

ProSomnus, Inc. is an average overall performer. With a 'C' rating of 47.4 for overall impact (36th percentile compared to all companies), ProSomnus, Inc. ranks 145th out of 155 industry peers, behind Hologic, American Shared Hospital Services, Accuray and 141 others, and ahead of Sebia, Austco Healthcare, Nova Eye Medical and 7 others. On top material causes for ProSomnus, Inc.'s industry (Healthcare Equipment), ProSomnus, Inc. performs well in Child and Maternal Health (95.1 score) and Technology Innovation (95.1) and performs poorly in Humane Treatment of Animals (39.4 score), Disaster Readiness and Effective Aid (30.8), Sanitation Access (32.7) and 8 other causes where it received a 'D' or 'F' score.
Impact
Cause OSA
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
2006
Employees
136
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Equipment
SASB industry
Medical Equipment & Supplies
Headquarters
Ca, United States
Share classes
OSA
Description
ProSomnus, Inc. operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea. The company sells its products to sleep dentists, sleep physicians, primary care providers, otolaryngologists, and other integrated healthcare service providers through a direct sales force. ProSomnus, Inc. is headquartered in Pleasanton, California.
Material causes
Ethos considers the following causes material for ProSomnus, Inc., based on its industry sub-industry Health Care Equipment. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.